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Cost-Effectiveness and Value of Information Analysis of Brief Interventions 
to Promote Physical Activity in Primary Care 
Abstract 
Background: Brief interventions (BIs) delivered in primary care have shown potential to increase physical 
activity levels and may be cost-effective, at least in the short term, when compared with usual care. 
However, there is limited evidence on their longer-term costs and health benefits. 
Objectives: To estimate the cost-effectiveness of BIs to promote physical activity in primary care and to 
guide future research priorities using value of information analysis. 
Methods: A decision model was used to compare the cost-effectiveness of three classes of BIs that have 
been used, or could be used, to promote physical activity in primary care: (1) pedometer interventions, (2) 
advice or counselling on physical activity and (3) action planning interventions. Published risk equations 
and data from the available literature or routine data sources were used to inform model parameters. 
Uncertainty was investigated with probabilistic sensitivity analysis, and value of information analysis was 
conducted to estimate the value of undertaking further research. 
Results: In the base-case, pedometer interventions yielded the highest expected net benefit at a 
willingness-to-pay of £20,000 per quality-adjusted life-year. However, there was a great deal of decision 
uncertainty: the expected value of perfect information surrounding the decision problem for the NHS 
Health Check population was estimated at £1.85billion. 
Conclusion: Our analysis suggests that pedometer-based BIs are the most cost-effective strategy to 
promote physical activity in primary care, and that there is potential value in further research into the cost-
effectiveness of brief (i.e. less than 30 minutes) and very brief (i.e. less than 5 minutes) pedometer-based 
interventions in this setting. 
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Introduction 
Physical inactivity is a major public health problem associated with a significant burden of chronic disease, 
including type 2 diabetes, cardiovascular disease, some cancers and mental health problems [1-3]. 
Despite the well-documented health benefits of physical activity [4-7], in 2010, 33% of adults aged 18 
years and over in high-income countries were insufficiently active: i.e. they did not meet the current World 
Health Organization (WHO) recommendations [8]. In England, using self-reported measures in 2012, 61% 
of adults aged 19 and over met the current UK guideline [9] for moderate/vigorous physical activity [10], a 
figure virtually unchanged since the 2008 Health Survey for England (HSE), reporting 59%. However, 
when physical activity was measured objectively using accelerometers, in 2008 only 6% of men and 4% 
of women aged 16 and over met the recommended physical activity level [11]. 
Physical inactivity is also associated with a considerable economic burden, accounting for 1.5% to 3% of 
total direct healthcare costs in high income countries [12]. The annual societal cost of physical inactivity in 
England (comprising the National Health Service (NHS) costs plus the value of morbidity/premature 
mortality-related lost productivity) is estimated at £8.2 billion per year, with an additional £2.5 billion for 
the contribution of physical inactivity to obesity-related costs [1].  
Intensive face-to-face physical activity interventions delivered in primary care or community settings 
targeting sedentary adults can be effective at increasing activity levels [13]. They have been found to 
represent good ‘value for money’ as they can increase self-reported physical activity at reasonable cost 
[14, 15]. In recent years, there has been interest in brief interventions (BIs), defined as having a maximum 
duration of 30 minutes [16, 17], to promote physical activity in a primary care setting [18-20]. Systematic 
reviews and meta-analyses of randomised controlled trials (RCTs) showed that BIs, e.g. brief exercise 
advice/counselling delivered in primary care, increase physical activity [20, 21] and are cost-effective [15, 
22] over the short-term (twelve months or less). However, the evidence on the longer-term costs and 
consequences of BIs has been sparse to date. 
Findings from published RCTs of physical activity interventions are not sufficient on their own to inform 
decision makers about the cost-effectiveness of intervention strategies [23]. Evidence on the long term 
cost-effectiveness of health interventions is essential to inform resource allocation decisions aimed at 
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maximising health gains to the population from limited available resources [14]. Using a discrete event 
simulation model, we aim to evaluate the long-term cost-effectiveness of BIs to promote physical activity 
in adults eligible for an NHS Health Check in primary care.  
If BIs are cost-effective, this raises the question of whether ‘very brief interventions’ (VBIs) could also be 
cost-effective. VBIs, defined as lasting no more than five minutes [18], are of interest as they can be 
delivered as part of a primary care consultation such as the NHS Health Check [24]. This is offered every 
five years to all adults in England aged 40-74 years without known pre-existing vascular disease and is 
intended to assess risk of certain conditions, including type 2 diabetes and heart disease, and provide 
preventative advice and interventions where indicated [25].  
In this paper we present an economic evaluation of three classes of BIs (plus no intervention), reporting 
the incremental cost per quality-adjusted life-year (QALY) gained over 10 years. We also report a value of 
information analysis, a method to predict the return on investment in further research [26-28]. This 
information will inform the design of further research into the effectiveness and cost-effectiveness of VBIs 
delivered as part of the NHS Health Checks. 
Methods 
Study population 
We used data from the 2011 HSE to generate a simulated cohort of 10,000 adults aged 40-74 years who 
do not have an existing diagnosis of diabetes, hypertension, cardiovascular or renal disease, representing 
the NHS Health Check population [25].  
The PACE model 
We developed a discrete event simulation model, the Physical Activity Cost Effectiveness (PACE) model 
in R [29] to estimate the cost-effectiveness of BIs. The model firstly generates a cohort of 10,000 
representative individuals of the English population. It then follows each individual, predicting the 
incidence of chronic disease, mortality and associated costs and outcomes over ten years, specified with 
risk equations and data derived from the literature [30-38]. The model includes type 2 diabetes and 
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associated complications, heart disease, stroke and physical inactivity and obesity-related cancers 
(breast, colorectal, lung or kidney cancer). Increased physical activity is assumed to influence risk factors 
such as reduced blood pressure, cholesterol level and glycated haemoglobin (HbA1c). Modification of 
these risk factors leads to changes in the risk of chronic disease and comorbidities, such as reduced risk 
of cardiovascular disease. A decrease in chronic disease and comorbidities leads to a reduction in costs 
and to the prevention of a decrease in quality of life (Fig. 1). Effectiveness data for each comparator are 
entered in the model as an increase in metabolic equivalent (MET) hours per week compared with no 
intervention, which in turn influences risk of chronic disease. The random search method [39] was used to 
calibrate the model against seven calibration targets. Weighted mean deviation was used to assess the 
goodness-of-fit of calibration results [40]. Full details of the model and calibration are in Appendix 1 in 
Supplemental Materials. 
Data inputs and sources 
Model inputs 
Data on demographic characteristics of individual participants (age, gender, ethnicity) were derived from 
the UK Office for National Statistics [41, 42]. The risk factor profile (systolic blood pressure, total 
cholesterol, high density lipoprotein cholesterol, body mass index, smoking status and HbA1c) and 
prevalence of type 2 diabetes and cardiovascular events (ischaemic heart disease, myocardial infarction 
(MI), stroke and heart failure) for individual participants in the cohort was generated using data from the 
2011 HSE [43]. The severity of breast cancer was classified according to Nottingham Prognostic Index 
(NPI) prognostic groups – ductal carcinoma in situ (DCIS), excellent, good, moderate and poor [44] – and 
age-specific prevalence data for breast cancer was taken from the estimates for 2008 in the UK [45]. The 
baseline parameter values for colorectal cancer were derived from Frazier et al [35] and applied to the 
baseline population to generate prevalence data for colorectal cancer. The baseline prevalence data of 
lung and kidney cancers were based on estimates from Cancer Research UK [37, 46].  
Interventions 
We selected three classes of BIs: pedometer interventions, advice/counselling in primary care, and action 
planning interventions. Evidence of effectiveness was extracted from published meta-analyses of RCTs 
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[47-49]. The three classes are somewhat heterogeneous, therefore descriptions of the classes (and 
associated costings) below reflect the scope of interventions included in the respective meta-analyses. 
This selection of BIs was based on the strength of evidence of effectiveness and their relevance in a 
primary care setting. Full details are provided in Appendix 2 in Supplemental Materials. We also included 
current practice where no physical activity intervention is delivered. 
Pedometer-based interventions: Participants were given a pedometer to wear and encouraged to view 
and record their daily step counts. They were also asked to set a physical activity goal such as to walk 20 
minutes on all or most days of the week, or walk 10,000 steps on five days per week. In some 
interventions, participants received individualised exercise feedback or additional ‘behavioural counselling’ 
from a nurse or physiotherapist.  
Advice or counselling in primary care: Typically, participants received written materials with exercise 
advice or an exercise prescription; and two or more sessions of advice or counselling on physical activity. 
Advice or counselling was mostly delivered face-to-face, in some cases by phone (or both). In most cases, 
the interventions were delivered by primary care doctors or nurses. 
Action planning interventions: These BIs employed ‘implementation intentions’, a commonly used form 
of action planning. Participants were asked to formulate an action plan for physical activity in the format of 
what, when and where, and to record their action plan in a logbook or calendar. In most interventions, 
participants were encouraged to write down an action plan assisted by a trained interviewer.  
Current practice: Participants received no intervention.  
Short-term effectiveness of interventions 
The intervention effects of the BIs were converted to MET-hours by estimating the time spent in activities 
with higher MET intensities as a result of the intervention [50]. We extracted physical activity outcomes 
from individual studies included in the three meta-analyses which were translated into MET-hours by 
selecting the estimates from the compendium of physical activity [51]. Finally, we updated the meta-
analysis using translated values (MET-hours). However, it was not possible to translate intervention 
effects into MET-hours for five of the nineteen RCTs included in the meta-analysis of action planning 
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interventions [47] as either these studies did not provide details on changes in intensity, duration and/or 
frequency of activity required for MET-hours translation, or the outcome was expressed in composite units 
(e.g. a sum of scores where responses were rated on a scale). Thus, we excluded those five studies. 
Intervention costs 
We first extracted resource use data based on the intervention description provided for individual studies 
in the meta-analyses. We then costed each intervention based on the quantities of resources used 
multiplied by the unit cost of each resource component. The cost per participant was then evaluated as 
weighted average of intervention costs from each RCT in the meta-analysis (Table 1). Full details on 
translating the intervention effects into MET-hours and costing of each intervention are provided in 
Appendix 2 in Supplemental Materials. 
Disease costs and health outcomes 
The price year and currency of the study was 2011 UK pounds sterling (£). The annual costs associated 
with each health state were derived from previous studies [33, 36, 52-63]. The health outcomes were 
evaluated in QALYs. Utilities for health states included in the model were obtained from published 
sources [64-69]. Details on costs and utilities related to comorbid disease conditions in the model are 
available in Appendix 1 in Supplemental Materials. We performed the analysis from the English NHS 
perspective to estimate the costs and benefits of BIs over a ten-year time horizon. All health outcomes 
and costs were discounted at 3.5% per annum [70]. 
Probabilistic sensitivity analysis 
We performed a Monte-Carlo simulation (n=10,000 iterations) to simultaneously account for uncertainty in 
all input parameters (Appendix 1 in Supplemental Materials). The net monetary benefit (NB; UK 2011 £), 
that is, the health effect (QALYs) multiplied by a societal willingness-to-pay (WTP) per QALY gained 
minus the cost was calculated for each BI [71]. At any given WTP threshold, the cost-effective 
intervention was identified as the one with the highest expected NB, which is mathematically identical to 
sequentially identifying the most cost-effective intervention with an incremental cost-effectiveness ratio 
(ICER) below the threshold compared with the next best non-dominated alternative. We constructed cost-
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effectiveness acceptability curves (CEACs) to illustrate the decision uncertainty surrounding the adoption 
of BIs, conditional on the WTP per QALY [72]. The NBs were estimated at a WTP of £20,000 per QALY.  
Scenario analyses 
The sustainability of intervention effects over time plays an important role in the cost-effectiveness 
analysis. There is considerable uncertainty about the maintenance of any effects of BIs as very few 
studies have follow-up measurement beyond one year. We performed sensitivity analysis with decay 
rates for the intervention effect ranging between 0% (lifelong behaviour change) and 100% (behaviour 
change reversed to baseline after the first year post-intervention). In the base case, we assumed that the 
intervention effects were sustained for the first year, but decayed at a rate of 55% per annum thereafter. 
We also evaluated the cost-effectiveness of BIs if they were repeated once every two, five and ten years, 
and finally explored the direct impact of a short-term quality of life boost from increased physical activity. 
Only a few studies have measured these short-term improvements in the general population [73, 74], as 
most studies focus on older adults and people with chronic conditions [75]. A pragmatic RCT evaluating 
the national exercise referral scheme in Wales estimated a utility boost of 0.03 +/- 0.023 [76]. We added 
this in the first year of intervention to reflect the short-term benefits of physical activity. 
Value of information analysis 
We had originally intended to conduct a value of information analysis on the entire decision problem. 
However, due to computational difficulties for such a complex model, we limited this to a comparison 
between the pedometer BIs and current practice. This was chosen as we selected a pedometer-based 
intervention as the most promising VBI for trial evaluation in our wider research programme [77]. Thus the 
analysis established whether or not there was an economic case for a trial of a pedometer-based BI. 
We estimated the expected value of perfect information (EVPI) as the difference between the expected 
value of decision (i.e. the maximum expected NB) with perfect information and that with current 
information [78]. As the value for additional information is related to the size of the eligible population, the 
EVPI was multiplied with the estimated Health Check population to estimate the population EVPI. Given 
that approximately 30% of the population are on a primary care disease register [79], the eligible Health 
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Check population (i.e. adults aged 40-74) over 10-years equates to approximately 19.1 million. The 
population EVPI provides the upper bound on the value of future research. To identify a parameter or 
group of parameters that contribute to most of the overall decision uncertainty and for which future 
research is the most promising, we estimated the expected value of partial perfect information (EVPPI) 
[78, 80, 81]. For this, we grouped model parameters into the following six sub-groups: research on 1) 
intervention effects, 2) health state utilities, 3) costs, 4) risk of MI, 5) risk of stroke, and 6) parameters 
used in systolic blood pressure equation. The EVPPI was calculated using a two-level Monte-Carlo 
sampling loop, in which the parameter(s) of interest were sampled 500 times in the outer loop, and for 
every iteration the remaining parameters were sampled 1,000 times in the inner loop [82, 83]. Multiplying 
the EVPPI values per patient with the eligible Health Check population resulted in the population EVPPI.  
Results 
Cost-effectiveness analysis 
In the base-case, the point estimates for per person costs and QALYs for all interventions were similar 
(Table 2). Pedometer BIs dominated both advice/counselling and action planning BIs, i.e. pedometer BIs 
were both less expensive and more effective. When compared with current practice, all three BIs were 
both more effective and more costly. 
Analysis of Uncertainty 
The scatterplot of incremental costs versus incremental QALYs (comparing each BI with current practice) 
for the 10,000 iterations showed points scattered across all four quadrants of the cost-effectiveness plane, 
with the majority of the points overlapping with each other (Fig. 2A). The CEAC (Fig. 2B) showed that 
pedometer BIs were the optimal option in 56% of the 10,000 model simulations at a WTP of £20,000 per 
QALY. Advice/counselling intervention was optimal in 22% of the iterations at a WTP of £20,000 per 
QALY. Current practice and action planning interventions had similar CEACs showing less than 13% 
probability of being the most cost-effective. 
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Scenario analyses 
As the intervention decay rate increases, BIs become less cost-effective (Fig. 2C). At higher intervention 
decay rates, the expected NBs of all interventions were quite similar, ultimately dropping below that of 
current practice. This is to be expected as the treatment effect declines to that of current practice. For the 
scenario analysis with the interventions being repeated once every two, five and ten years (Fig. 2D) 
respectively, pedometer BIs were found to be the optimal option for all three repeat year scenarios. The 
expected NB for pedometer interventions was highest when the intervention was repeated once every 
two years.  
The inclusion of short-term health gains (utility boost) from increased physical activity (Appendix Table 4.1 
in Supplemental Materials) had similar results as the base-case analysis, with pedometer BIs as the most 
cost-effective intervention. However, there was a parallel shift upwards for the three BIs. The probabilities 
of pedometer and advice/counselling BIs being cost-effective at a WTP of £20,000 per QALY increased to 
61% and 24%, respectively, up from 56% and 21% in the base-case scenario. 
Value of information analysis 
At a WTP of £20,000 per QALY, the base-case per person EVPI associated with a decision between 
pedometer BIs and current practice was £97, or £1.85bn to the NHS Health Check population (Fig. 3A). 
This means that, at a WTP of £20,000 per QALY, the upper limit for research into which intervention is 
most cost-effective is £1.85 bn. Among the groups of different parameters, intervention effects had the 
highest population EVPPI of £708 million followed by costs (£690) and risk of stroke (£684 million) 
parameters at a WTP of £20,000 per QALY (Fig. 3B).  
 
Discussion 
What this study shows 
In this study we estimated the expected long-term costs and health outcomes of BIs that could potentially 
be used to increase physical activity among apparently healthy adults who are eligible for NHS Health 
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Checks in primary care in England. The health benefits of increasing physical activity levels were 
simulated using effects of BIs reported in the meta-analyses of RCTs, and synthesised in a decision 
analytic cost-effectiveness model. In the base-case analysis, we found that pedometer BIs were dominant, 
i.e. they were less costly and had better outcomes (QALY gains) than other BIs. The value of information 
analysis for pedometer BIs versus current practice showed that the expected value of conducting further 
research to eliminate decision uncertainty was £1.85 billion, assuming a time horizon of ten years, and 
that further research that would eliminate uncertainty in intervention effects for the NHS Health Check 
population would be worth £708 million (Fig. 3B). We explored the impact of repeating the BI, and 
repetition every two years seems to be the most efficient interval. 
Care must be taken in interpreting the value of information statistics. A new study will not eliminate 
uncertainty, but is expected to reduce it. Therefore, the expected value of sample information (EVSI) of 
such a study will be less than the EVPI. We attempted to calculate the EVSI and the expected net gain of 
sampling (ENGS, defined as the EVSI less the total cost of a proposed study) but due to computational 
demands we were unable to generate meaningful and stable results. Nevertheless, given the size of the 
EVPI, it may be reasonable to suggest that there is scope for further research to be efficient. Whilst all 
parameter groups had a similar EVPPI, the highest was in intervention effectiveness. 
Implications for policy 
Our results show that pedometer BIs appear to be a cost-effective way of promoting physical activity 
when compared with other BIs such as advice or counselling in primary care. Delivering the pedometer BI 
once every two years appears to be the most efficient repeat interval. However, this is contingent on the 
assumed ‘decay rate’ of the intervention effect, and the ability of repeat contacts to maintain physical 
activity.  
The value of information analysis suggests that there may be value in further exploring the effectiveness 
of a general class of pedometer-based brief interventions: the population EVPI of £1.85bn is certainly 
very much above the cost of any plausible design of a RCT, suggesting that further research could be 
efficient. However, a definitive answer requires calculation of the expected net gain of sampling for a 
particular trial. Given that this analysis is part of a research programme on VBIs, the logical next question 
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is whether it is worth investigating whether a shortened VBI pedometer intervention, incorporated as part 
of the NHS Health Check, would be of value. Given that (1) it is highly likely that future research into 
pedometer-based BIs is efficient, and (2) less is known about the effectiveness and cost-effectiveness of 
VBIs, it is reasonable to suggest that exploration of the effectiveness and cost-effectiveness of a 
pedometer-based VBI is efficient. 
Comparison with other studies 
Our cost-effectiveness results were mostly more favourable than the Over et al [84] and Gulliford et al [85] 
studies of pedometer and brief exercise advice/counselling interventions, respectively, but were not as 
favourable as reported by Cobiac et al [86] for pedometer interventions. This could be because 
intervention costs in our study were lower than in Over et al [84] and Gulliford et al [85]. However, Cobiac 
et al [86] used much lower intervention costs per person than our model. In addition, differences in the 
target population, modelling methods, inclusion of diseases/co-morbidities and short-term health gains, 
and assumptions on intervention decay could explain the observed differences in the cost-effectiveness 
results. Two modelling studies [85, 86] were driven by a disease burden modelling strategy and Anokye 
and colleagues [87] included short-term mental health gains in their cost-effectiveness analysis. However, 
in their analyses [85, 87] they did not take into account any decay in the intervention effects over time. 
Strengths and limitations 
Our model is comprehensive and complex in terms of the inclusion of physical activity dose-response 
relationship and comorbidities related to physical inactivity and obesity. Our analysis was based on meta-
analyses of RCTs evaluating the effect of BIs on physical activity levels, incorporated into a 
comprehensive decision model to project costs and outcomes associated with each intervention (plus 
current practice) over the long term. We included interventions that are low cost and relevant to a primary 
care setting.  
However, there are limitations to our approach, including the structure of the model and data inputs. Not 
all the data sources, e.g. transition probabilities and health state utilities were available for the NHS 
Health Check population. We only included disease conditions related to physical inactivity and obesity 
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for which dose-response evidence was available. Only one of the meta-analyses [49] focused on 
interventions delivered in primary care, and all three meta-analyses included several studies in which 
participants had a chronic condition. However, based on the intervention descriptions (Appendix 2 in 
Supplemental Materials), many of them are arguably amenable to delivery in a primary care setting and 
suitable for apparently healthy populations. Translating a wide range of physical activity measures used in 
the primary studies into a common metric (here: MET hours) entails potential for error. It was not always 
possible to translate intervention effects directly into MET-hours. Although we excluded five of the 
nineteen studies included in the meta-analysis of action planning interventions [47], the intervention effect 
size after excluding those five studies did not change.  
The true rate of decline in intervention effects and how it differs across interventions over time is unknown, 
as much of the evidence is based on studies with short (i.e. 12 months or less) follow-up [88, 89]. 
Moreover, the ‘active ingredients’ differ across interventions as well as the extent to which interventions 
are able to prompt enactment of behaviour change techniques in daily life (e.g. goal setting, action 
planning) and only the meta-analysis of advice/counselling interventions [49] included studies with 12 
months or longer of follow-up.  
In the base-case analysis, we assumed that the intervention effects are sustained for the first year and 
decay at a rate of 55% per annum thereafter, irrespective of intervention duration and length of follow-up. 
This assumption may have overestimated the intervention effects of pedometers and action planning 
interventions, leading to an underestimation of the ICER. In addition, our assumptions on sustained 
effects of intervention beyond one year is arbitrary and may be a strong assumption. However, previously 
reported modelling studies [84, 86, 90] assumed similar base-case decay rates, varying between 50% 
and 55%. 
The effect of pedometers BI was based on a meta-analysis that included only 277 participants in total. In 
addition, the pooled intervention effects of BIs included in this analysis are based on a broad range of 
similar interventions and not all the included interventions are sufficiently brief to be used in primary care. 
Hence this category represents a broad class of interventions. Although “no intervention” was the typical 
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comparator in the studies included in the three meta-analyses, some of the studies evaluated the 
intervention against a comparator intervention only (Appendix 2 in Supplemental Materials).  
Conclusion 
In conclusion, based on currently available data, pedometer-based BIs appear the most cost-effective 
strategy to increase physical activity in primary care. However, there is substantial uncertainty, and BIs 
yielded only relatively small health benefits. The sensitivity analysis suggests that repeating BIs once 
every two years could be the most efficient repeat interval. If further research were to be conducted, 
research on the effectiveness of brief and very brief pedometer BIs in primary care would be a worthwhile 
investment. 
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TABLES 
Table 1 – Intervention effects and costs associated with implementing BIs promoting physical 
activity 
Brief interventions No. of 
studies 
Total no of 
participants 
Median 
(range) 
duration of  
follow-up 
Unit of 
measurement; 
intervention effect 
(95% CI) 
Effect (in MET-
hours per day) 
Intervention 
costs* 
Source 
Advice/counselling 
in primary care 
9 RCTs 3,445 12 months Standardised 
mean difference; 
0.25 (0.11 – 0.38) 
0.33 
(0.16 – 0.49)  
£71.26 [49] 
Action planning 
interventions 
14 
RCTs 
1,864 10 (2–52) 
weeks 
Standardised 
mean difference; 
0.23 (0.10 – 0.35) 
0.05 
(0.02 – 0.08) 
£33.21 [47]  
Pedometer 
interventions 
8 RCTs 277 11 (4–24) 
weeks 
Increase in steps 
per day; 
2,491 (1,098 – 
3,885) 
1.06 
(0.47 – 1.65) 
£54.33 [48]  
Current practice 
(‘doing nothing’) 
  - - - -  
*All costs are inflated to 2011 UK £ sterling using the Hospital and Community Health Services (HCHS) index [53] 
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Table 2 – Cost-effectiveness of brief interventions over 10 years (base-case costs, QALYs and 
NBs) 
 
Brief intervention Mean cost (SE) Mean QALY 
(SE) 
Mean NB* (SE) ICER 
Current practice £1,712 (583)  7.848 (0.228) £ 155,254  (5,072) - 
Action planning £1,738  (583) 7.851 (0.228) £ 155,291  (5,079) 
Extendedly 
dominated 
Advice/counselling in 
primary care 
£1,758  (580) 7.857 (0.229) £ 155,378  (5,084) 
Dominated by 
pedometers 
Pedometer 
interventions 
£1,723  (579) 7.864 (0.229) £ 155,549  (5,097) 
£ 687.50 
*NB calculated at a WTP of £20,000 per QALY, ICER: incremental cost-effectiveness ratio 
 
